May 2015 FDA Recall Drug by Teva Pharmaceuticals Usa
D-1087-2015 - Failed Impurities/Degradation Specifications
This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on May 7, 2015 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1087-2015
Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.
05-07-2015
06-03-2015
233,364 Inhalers
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Teva Pharmaceuticals USA
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide and Peurto Rico
11-15-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For Oral Inhalation with QVAR Actuator Only, 120 metered inhalations, Rx Only, Mktd by Teva Respiratory, LLC., Horsham, PA. mfd by 3M Drug Delivery Systems, Northridge, CA, NDC 59310-0202-12
Batch or Lot Expiration Information
Lot# s:130449, 130450; Exp. Date: 12/2015